Satellos Bioscience (MSLE) Change in Accured Expenses (2025 - 2026)
Satellos Bioscience's (MSLE) quarterly Change in Accured Expenses came in at $423000.0 in Q1 2026, up 147.74% year-on-year from $170741.7 in Q1 2025, and up 147.74% on a QoQ basis from -$886000.0 in Q1 2025.
Satellos Bioscience (MSLE) Change in Accured Expenses (2025 - 2026) Analysis & Trends
Satellos Bioscience (MSLE) has 2 years of Change in Accured Expenses data on file, last reported at $423000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -16.82 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -16.74 Mn |
| 10 | Satellos Bioscience | 148.71 Mn | 148.71 Mn | - | 423,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 423,000.00 |
| Mar 31, 2026 | 423,000.00 |
| Mar 31, 2025 | -886,000.00 |
| Mar 31, 2025 | -886,000.00 |